InvestorsHub Logo

EYEBUYSTOX

08/11/11 6:33 PM

#125024 RE: DewDiligence #125023

FCSC - Manufacturing costs of LaViv and whether or not the company has increased efficiency since it last sold the product several years ago are unknown. The 10Qs over the coming quarters will answer those questions.

However, it's naive of you to think VRX would have no interest in a product that could be marketed to millions of acne scar sufferers with few other viable options.